GLP-1 Receptor Agonists and Musculoskeletal Outcomes: A Systematic Literature Review and Meta-Analysis
Charlotte Beaudart, Yveline Malréchauffé, Sophie van Heden, Dolores Sanchez-Rodriguez, André Scheen, Olivier Bruyère, Ali Mobasheri, Gustavo Duque, René Rizzoli, Jean-Yves Reginster, Jotheeswaran Amuthavalli Thiyagarajan · 2026
Read GLP-1 Receptor Agonists and Musculoskeletal Outcomes: A Systematic Literature Review and Meta-Analysis by Charlotte Beaudart, Yveline Malréchauffé, Sophie van Heden, Dolores Sanchez-Rodriguez, André Scheen, Olivier Bruyère, Ali Mobasheri, Gustavo Duque, René Rizzoli, Jean-Yves Reginster, Jotheeswaran Amuthavalli Thiyagarajan (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13615104.txt.
Description
Charlotte Beaudart and co-authors weigh how a class of diabetes and weight drugs affects bones, muscle, and joints in a 2026 review. The drugs, called GLP-1 receptor agonists, are now widely used. Their effects on the body's frame were, in the authors' words, completely misunderstood.
The team searched three databases through March 2025 for trials and real-world studies. Sixty papers passed, covering more than one and a quarter million people. Where two or more studies shared an outcome, results were pooled with a standard model. Subgroup and leave-one-out checks tested how firm the sums were. Evidence grades were assigned for each claim. The review gives clinicians a single map of what is known and what is not.
Catalog record
| CREATOR | Charlotte Beaudart, Yveline Malréchauffé, Sophie van Heden, Dolores Sanchez-Rodriguez, André Scheen, Olivier Bruyère, Ali Mobasheri, Gustavo Duque, René Rizzoli, Jean-Yves Reginster, Jotheeswaran Amuthavalli Thiyagarajan |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 118 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |